Introduction
Chiamydia trachomatis is an important pathogen in the female genital tract.' 2 Serious complications can occur, and vigorous treatment is indicated. 3 Tetracyclines and erythromycin stearate have been shown to be equally effective in eradicating chlamydiae from the cervix,4-6 but little information is available about the optimum dose and duration of treatment. The two to three week regimens in common use in the United Kingdom are based largely on studies of non-gonococcal urethritis in men and of chlamydial conjunctivitis.7 There is, however, some evidence to suggest that treating chlamydial infection of the cervix for one week may be as effective in eradicating chlamydiae as a longer course of treatment,4 5 89 although follow up periods were relatively short and differentiation between treatment failure and reinfection was not always possible.
The Reisolation of chlamydiae after treatment was regarded as possible reinfection in women who had had intercourse subsequently with a partner who was not known to be chlamydia negative. If these possible reinfections were excluded from analysis, the cure rates for the seven and 14 day treatment regimens were 94% (64/68) and 82% (51/62) respectively. This difference was not significant (X2 = 3*38; p>0 05).
Default reduced the numbers available for long term follow up. In women who were examined [10] [11] [12] [13] [14] [15] [16] weeks after completion of treatment, chlamydiae were reisolated from 1/29 of those treated for seven days and from 7/24 of those treated for 14 days (table) .
Clinical cervicitis was recorded in only 12 patients in each group and was present after eradication of chlamydia in five from each group.
There were no serious complications of treatment, but three women treated for seven days and five treated for 14 days were unable to complete the prescribed treatment because of epigastric discomfort or nausea.
Discussion
Although several studies have shown the activity of erythromycin and other antimicrobials in chlamydial infections in women,4-69 13 direct comparisons are difficult because of differences of dosage and duration of treatment. Oriel and Ridgway showed that erythromycin stearate was as effective as oxytetracycline when given for 14 days. 6 The results of our survey show that a seven day course of erythromycin stearate 500 mg twice daily is as effective in eradicating chlamydiae from the cervix as a 14 day course. There was no difference in clinical response between the two groups, and no suggestion that latency was more likely to occur after the shorter course.
Rather surprisingly, C trachomatis was isolated after treatment more often in the group who had been treated for 14 The possibility that chlamydial infection might become latent after treatment has been suggested.' In this study 53 women were examined 10-16 weeks after the completion of treatment. C trachomatis was isolated from eight, five of whom claimed to have had no intercourse since treatment; four of these had been given treatment for 14 days. All had had at least one negative culture after treatment. Although numbers were very small, the possibility of latent infection cannot be excluded.
Erythromycin stearate 500 mg twice daily given for seven days appears to be a safe, well tolerated, and effective treatment for uncomplicated chlamydial infection of the cervix. 
